Omeros News
Most Popular Omeros Story
Omeros hopes to raise up to $81.6M in IPO
IPO activity in the biotech arena continues to heat up with the news that Omeros filed to sell 6.8 million shares for up to $81.6 million. The money is promised for its mid- and late-stage drug Read more...
Latest Headlines
- April 1, 2011
- October 25, 2010
- March 31, 2010
- October 8, 2009
- September 17, 2009
- August 27, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
